Related Articles
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: A phase II trial
S-1 monotherapy for previously treated non-small cell lung cancer: A retrospective analysis by age and histopathological type
Feasibility of adjuvant chemotherapy with S-1 consisting of a 4-week administration and a two-week rest period in patients with completely resected non-small cell lung cancer
Examination of the clinical efficacy of eribulin and trastuzumab in HER2‑positive recurrent breast cancer
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer